Physician profile
Amy Liepert
NPI 1366611972
$21,870.06
in general payments reported to CMS, 2019-2025
9 companies · $20K in 2025
The $20K reported for 2025 was more than what 98% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $113 · 2023: $188 · 2024: $1,671 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Travel and Lodging: $2,579 · Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $18,500.00 |
| Travel and Lodging | $2,579.20 |
| Food and Beverage | $552.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,349.67 | 2024-2025 | |
| Boston Scientific Corporation | $188.39 | 2023-2024 | Spyglass, Spyglass Discover |
| Davol INC. | $125.44 | 2021 | |
| Ethicon US, LLC | $108.05 | 2022-2023 | Echelon; Endopath |
| Avita Medical Americas, LLC | $25.62 | 2024 | |
| Polynovo North America LLC | $21.57 | 2022 | |
| Teleflex LLC | $19.74 | 2024 | Quikclot |
| Lifenet Health | $17.94 | 2023 | |
| Vericel Corporation | $13.64 | 2023 | Nexobrid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Liepert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.